Association of Muscle-Strengthening and Aerobic Physical Activity With Mortality in US Adults Aged 65 Years or Older

Two pages on PainSci cite Webber 2022: 1. What Works for Chronic Pain? 2. Three happy exercise studies for pain patients 

PainSci notes on Webber 2022:

Webber et al studied the effect on all-cause mortality of muscle strengthening specifically — an emphasis on wearing out muscles relatively quickly by lifting heavy things, as opposed to huffing and puffing aerobically. They identified a robust drop in mortality, about 20% lower in people who did 2–6 weekly sessions compared to none or just one.

related content

• “Comparative efficacy of exercise therapy and oral non-steroidal anti-inflammatory drugs and paracetamol for knee or hip osteoarthritis: a network meta-analysis of randomised controlled trials,” Weng et al, British Journal of Sports Medicine, 2023.
• “Vigorous physical activity, incident heart disease, and cancer: how little is enough?,” Ahmadi et al, Eur Heart J, 2022.
• “Daily physical activity is negatively associated with thyroid hormone levels, inflammation, and immune system markers among men and women in the NHANES dataset,” Klasson et al, PLoS ONE, 2022.

This page is part of the PainScience BIBLIOGRAPHY, which contains plain language summaries of thousands of scientific papers & others sources. It’s like a highly specialized blog. A few highlights:

• Classical Conditioning Fails to Elicit Allodynia in an Experimental Study with Healthy Humans. Madden 2017 Pain Med.
• Topical glyceryl trinitrate (GTN) and eccentric exercises in the treatment of mid-portion achilles tendinopathy (the NEAT trial): a randomised double-blind placebo-controlled trial. Kirwan 2024 Br J Sports Med.
• Placebo analgesia in physical and psychological interventions: Systematic review and meta-analysis of three-armed trials. Hohenschurz-Schmidt 2024 Eur J Pain.
• Recovery trajectories in common musculoskeletal complaints by diagnosis contra prognostic phenotypes. Aasdahl 2021 BMC Musculoskelet Disord.
• Cannabidiol (CBD) products for pain: ineffective, expensive, and with potential harms. Moore 2023 J Pain.